The presence of white cell Jordan's anomaly in multiple Acyl-CoA dehydrogenase deficiency: A case report and implications for clinical practice.

Autor: Liu J; Clinical Laboratory, Boai Hospital of Zhongshan, Zhongshan, Guangdong, 528402, PR China., Ni W; Clinical Laboratory, Boai Hospital of Zhongshan, Zhongshan, Guangdong, 528402, PR China. Electronic address: niwenpengsha@126.com., Deng K; Clinical Laboratory, Boai Hospital of Zhongshan, Zhongshan, Guangdong, 528402, PR China., Chen Y; Clinical Laboratory, Boai Hospital of Zhongshan, Zhongshan, Guangdong, 528402, PR China., Gu G; Clinical Laboratory, Zhongshan Torch Development Zone People's Hospital, Zhongshan, Guangdong Province, 528437, 528436, PR China. Electronic address: 545941464@qq.com.
Jazyk: angličtina
Zdroj: Clinical biochemistry [Clin Biochem] 2024 Mar; Vol. 125, pp. 110735. Date of Electronic Publication: 2024 Feb 22.
DOI: 10.1016/j.clinbiochem.2024.110735
Abstrakt: Background: Multiple Acyl-CoA Dehydrogenase Deficiency (MADD), also known as Glutaric Aciduria Type II, is an exceptionally rare autosomal recessive genetic disorder that disrupts the metabolism of fatty acids, amino acids, and choline. It presents with a wide range of clinical manifestations, from severe neonatal-onset forms to milder late-onset cases, with symptoms including metabolic disturbances and muscle weakness. Jordan's anomaly is a distinctive morphological feature found in peripheral blood white cells and is typically associated with Neutral Lipid Storage Disease (NLSD).
Case Report: In our case report, the patient initially presented with symptoms of vomiting, abdominal pain, and altered consciousness. The presence of white cell Jordan's anomaly was detected in the blood smear. Subsequent serum tests revealed elevated levels of transaminases, creatine kinase, uric acid, and multiple acylcarnitines, while blood glucose and free carnitine levels were notably reduced. High-throughput sequencing confirmed heterozygous pathogenic variants in the electron-transferring flavoprotein dehydrogenase (ETFDH) gene, leading to the conclusive diagnosis of MADD. Following a three-month treatment regimen involving high-dose vitamin B2, coenzyme Q10, and other supportive interventions, the patient exhibited significant clinical improvement, ultimately resulting in discharge.
Conclusion: The identification of Jordan's anomaly in a pediatric patient with late-onset MADD sheds light on its broader implications within the realm of lipid storage myopathies. The significance of this finding extends beyond its conventional association with NLSD, challenging the notion of its exclusivity. This novel observation serves as a compelling reminder of the diagnostic significance this morphological abnormality holds, potentially revolutionizing diagnostic practices within the field.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: